A Tokyo-headquartered biotechnology company leveraging its GPCR structure-based drug discovery platform to build a diversified pipeline spanning neuropsychiatric disorders, rare diseases, and autoimmune conditions across global markets.
A Tokyo-headquartered biotechnology company leveraging its GPCR structure-based drug discovery platform to build a diversified pipeline spanning neuropsychiatric disorders, rare diseases, and autoimmune conditions across global markets.
